We are live on ! Find out more
AXGN icon

Axogen

177 hedge funds and large institutions have $1.6B invested in Axogen in 2018 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 56 increasing their positions, 56 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,724% more call options, than puts

Call options by funds: $2.19M | Put options by funds: $120K

163% more first-time investments, than exits

New positions opened: 50 | Existing positions closed: 19

67% more capital invested

Capital invested by funds: $957M → $1.6B (+$639M)

20% more funds holding

Funds holding: 147177 (+30)

7.16% more ownership

Funds ownership: 76.09%83.25% (+7.2%)

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

0% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 56

Holders
177
Holders Change
+30
Holders Change %
+20.41%
% of All Funds
4.04%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.11%
New
50
Increased
56
Reduced
56
Closed
19
Calls
$2.19M
Puts
$120K
Net Calls
+$2.07M
Net Calls Change
+$804K

AXGN Hedge Fund Activity: Q2 2018 in Review

177 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Axogen (AXGN) for Q2 2018, worth a combined $1.6B — up 67% from $957M a quarter earlier.

Buyers outnumbered sellers: 50 funds opened new AXGN positions and 19 closed out — a net gain of 31 holders — while 56 added to existing stakes and 56 trimmed.

The largest buyer was Marshall Wace, opening a new position worth an estimated $51.5M. The largest seller was Fidelity Investments, cutting an estimated $18.7M.

  • 177 institutional investors held Axogen (AXGN) as of Q2 2018, up from 147 in Q1 2018.
  • Funds reported $1.6B of Axogen stock for Q2 2018, up 67% quarter-over-quarter.
  • 50 funds opened new Axogen positions in Q2 2018 and 19 closed out, a net change of +31 holders.
  • The largest Axogen buyer in Q2 2018 was Marshall Wace, an estimated $51.5M added.
  • The largest Axogen seller in Q2 2018 was Fidelity Investments, an estimated $18.7M sold.

Based on aggregated 13F filings for Q2 2018.